Todd Foley

RYTM

Todd Foley serves as Director at Rhythm Pharmaceuticals, Inc. (RYTM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$4.19M

Total Sells

1 trades

$25.10M

Net Position

Net Seller

$20.91M

Companies Traded

AKTS, RYTM

Active Period

Mar 2021 – Jan 2026

2 total trades

Most Recent

Buy AKTS

Jan 12, 2026 · $4.19M

Todd Foley's Insider Trading at Rhythm Pharmaceuticals, Inc. (RYTM)

Buys

0 · $0.00

Sells

1 · $25.10M

Total Shares Bought

Total Shares Sold

1,000,000

RYTM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 16, 2021	Sell	1,000,000	$25.10	$25.10M	909,258

Todd Foley's Insider Trading at Aktis Oncology, Inc. (AKTS)

Buys

1 · $4.19M

Sells

0 · $0.00

Total Shares Bought

232,870

Total Shares Sold

AKTS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 12, 2026	Buy	232,870	$18.00	$4.19M	0

Related Insiders

Christopher Paul German

officer: Corporate Controller & CAO

RYTMSell · Mar 6, 2026

Hunter C Smith

officer: Chief Financial Officer

RYTMSell · Feb 19, 2026

Helen Susan Kim

Director

AKTSBuy · Jan 12, 2026

GADICKE ANSBERT

10% Owner

AKTSBuy · Jan 12, 2026

Pamela J. Cramer

Chief Human Resources Officer

RYTMSell · Dec 15, 2025

Joseph Shulman

Chief Technical Officer

RYTMSell · Nov 3, 2025

Alastair Garfield

Chief Scientific Officer

RYTMSell · Jul 3, 2025

MCGIRR DAVID W J

Director

RYTMSell · Jun 5, 2025

Explore More Insider Trading Data

RYTM Insider Trading Activity

View all insider trades at Rhythm Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity